Profil
Wenjiang Ma worked as a Research Associate at Morgan Stanley & Co. LLC from 2021 to 2023.
Then worked as an Investment Analyst at PFM Health Sciences LP from 2023 to 2025.
Followed by a position as a Research Analyst at Cantor Fitzgerald & Co. from 2025 to 2026.
Education includes an undergraduate degree from Peking University conferred in 2009 and a doctorate from the University of Wisconsin conferred in 2014.
Anciens postes connus de Wenjiang Ma
| Sociétés | Poste | Fin |
|---|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/04/2026 |
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Analyst-Equity | 01/02/2025 |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/09/2023 |
Formation de Wenjiang Ma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
PFM Health Sciences LP
PFM Health Sciences LP Investment ManagersFinance PFM generally uses bottom-up analysis in an attempt to identify transformational changes, trends, investment themes and core investment opportunities across asset classes and geographies. Their investment strategies are currently (1) Healthcare, which primarily invests in the global healthcare industry, (2) Growth Equity, which primarily invests in growth equity healthcare investments and (3) Biotech Opportunities, which primarily invests in biotech investments. The firm utilizes certain co-investment vehicles from time to time for investment opportunities in privately held companies. | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















